T1	p 61 98	patients with alcoholic liver disease
T2	p 438 475	patients with alcoholic liver disease
T3	p 478 566	Fifty patients with alcoholic liver disease ( 27 with cirrhosis , 23 without cirrhosis )
T4	p 896 915	15 healthy controls
T5	p 1688 1725	patients with alcoholic liver disease
T6	i 31 42	paromomycin
T7	i 119 137	placebo-controlled
T8	i 608 627	paromomycin sulfate
T9	i 647 654	placebo
T10	i 935 946	paromomycin
T11	i 950 957	placebo
T12	i 1125 1136	paromomycin
T13	i 1160 1167	placebo
T14	i 1318 1329	paromomycin
T15	i 1352 1359	placebo
T16	i 1396 1407	paromomycin
T17	i 1547 1558	paromomycin
T18	o 46 57	endotoxemia
T19	o 423 434	endotoxemia
T20	o 730 776	Endotoxin concentration , liver function tests
T21	o 849 872	Endotoxin concentration
T22	o 1040 1064	endotoxin concentrations
T23	o 1250 1273	endotoxin concentration
T24	o 1447 1470	endotoxin concentration
T25	o 1474 1494	liver function tests